Harvard Bioscience Stock
-
Your prediction
Harvard Bioscience Stock
Pros and Cons of Harvard Bioscience in the next few years
Pros
Cons
Performance of Harvard Bioscience vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Harvard Bioscience | - | - | - | - | - | - | - |
| Simulations Plus | -4.720% | 3.252% | 28.934% | -65.676% | -17.532% | -65.676% | -76.697% |
| Fonar Corp. New | 0.630% | 1.274% | 1.274% | 50.000% | 1.923% | 10.417% | 6.711% |
| MicroVision Inc | 0.730% | -3.575% | -7.762% | -45.568% | -26.375% | -69.073% | -96.337% |
Comments
News
Federal Reserve Chairman Jerome Powell Just Delivered Fantastic News for Stock Market Investors
Ongoing geopolitical tensions in the Middle East have triggered a surge in oil prices, stoking fears of an inflation spike that could derail the U.S. economy. The last time inflation suddenly
Better Buy: Bitcoin vs. Ethereum
With Bitcoin (CRYPTO: BTC) down 47% from its all-time high of $126,000 just a few months ago, it's perhaps no surprise that crypto investors are starting to look elsewhere for opportunities.
For
Harvard University's Investment Manager Loads Up On 3.87M ETHA Shares
According to a SEC filing dated Feb. 13, 2026, Harvard Management Co. Inc. established a new position in the iShares Ethereum Trust ETF (NASDAQ:ETHA), acquiring 3,870,900 shares. The estimated


